Nonalcoholic Fatty Liver Disease and Cardiovascular Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|14|2403-2411

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.14, 2014-04, pp. : 2403-2411

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does Non-Alcoholic Fatty Liver Disease (NAFLD) Increase Cardiovascular Risk?

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 8, Iss. 4, 2008-12 ,pp. : 301-307

Bentham Science Publishers

Access to resources Recommend Favorite

Nonalcoholic fatty liver disease: a review

By Poordad F Fred  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 3, 2005-08 ,pp. : 661-670

Informa Healthcare

Access to resources Recommend Favorite

Current treatment for nonalcoholic fatty liver disease

By Katsiki Niki   Athyros Vasilios G   Karagiannis Asterios   Mikhailidis Dimitri P  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 13, 2011-09 ,pp. : 2141-2142

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for non-alcoholic fatty liver disease

By Federico Alessandro   Niosi Marco   Vecchio Blanco Camillo Del   Loguercio Carmela  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 145-158

Informa Healthcare

Access to resources Recommend Favorite

Novel therapeutic targets for nonalcoholic fatty liver disease

By Eguchi Akiko  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 7, 2013-10 ,pp. : 773-779

Informa Healthcare

Access to resources Recommend Favorite